| Source of Funding | FY 2009 Actual | FY 2010 Estimate | FY 2011 PB |
|---|---|---|---|
| Appropriation | $1,080,796,000 | $1,110,229,000 | $1,142,337,000 |
| Type 1 Diabetes | 0 | 0 | 0 |
| Rescission | 0 | 0 | 0 |
| Supplemental | 0 | 0 | 0 |
| Subtotal, adjusted appropriation | 1,080,796,000 | 1,110,229,000 | 1,142,337,000 |
| Real transfer under Director's one-percent transfer authority (GEI) | -1,792,000 | 0 | 0 |
| Comparative transfer to NLM for NCBI assessment | -171,000 | -264,000 | 0 |
| Comparative transfer to NLM for Public Access assessment | -153,000 | -165,000 | 0 |
| Comparative transfer under Director's one-percent transfer authority (GEI) | 1,792,000 | 0 | 0 |
| Unobligated balance, start of year | 0 | 0 | 0 |
| Unobligated balance, end of year | 0 | 0 | 0 |
| Subtotal, adjusted budget authority | 1,080,472,000 | 1,109,800,000 | 1,142,337,000 |
| Unobligated balance lapsing | 0 | 0 | 0 |
| Total obligations | 1,080,472,000 | 1,109,800,000 | 1,142,337,000 |
Excludes the following amounts for reimbursable activities carried out by this account: FY 2009 - $8,278,000 FY 2010 - $8,278,000 FY 2011 - $8,278,000 Excludes $15,882,000 Actual in FY 2009; Estimate $16,000,000 in FY 2010 and Estimate $16,200,000 in FY 2011 for royalties.